GW Pharma

1 Story

Pot-Based Drug Poised for FDA OK

Sativex for cancer pain already in advanced clinical trials

(Newser) - A company developing a marijuana-based mouth spray for cancer pain is hoping for FDA approval by next year. British firm GW Pharma is already carrying out advanced clinical trials for Sativex, the first pharmaceutical developed from raw marijuana, reports AP . Sativex contains marijuana components delta 9-THC and cannabidiol, and has...

1 Story
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.